维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="Sturis"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Computer model for mechanisms underlying ultradian oscillations of insulin and glucose显示文摘	Sturis J Polonsky K S Mosekilde E		0，，05：	1
2	Bedtime Administration of NN2211,a Long-Acting GLP-1 Derivative,Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes显示文摘	Claus B Juhl Malene Hollingdal Jeppe Sturis	2002	Diabetes2002，51，：	1
3	GLP-1 derivative liraglutide in rats with β-cell deficiencies:influence of metabolic state on β-cell mass dynamics显示文摘	Sturis J Gotfredse CF Romer J		0，，01：	1
4	Modeling the insulin-glucose feedback system:the significance of pulsatile insulin secretion显示文摘	Tolic I M Mosekilde E Sturis J		0，，03：	1
5	One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211)markedly improves 24h glycemia and alpha-and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes显示文摘	Degn KB Juhl CB Sturis J		0，，05：	1
6	GLP -I derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics显示文摘	Sturis J Gotfredsen C F Romer J	2003	Br J Pharmacol2003，140，1：	1
7	Bedtime administration of NN2211,a long-acting GLP-1 derivative,substantially reduces fasting and postprandial glycemia in type 2 diabetes 显示文摘	Juhl CB Hollingdal M Sturis J	2002	Diabetes2002，51，2：	1
8	Bedtime administration of NN2211,a long-acting GLP-1 derivative,substantially reduces fasting and postprandial glycemia in type 2 diabetes显示文摘	Juhl CB Hollingdal M Sturis J	2002	Diabetes2002，51，2：	1
9	The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose显示文摘	Chang AM Jakobsen G Sturis J	2003	Diabetes2003，52，7：	1
10	Beditime administration of NN2211 a long-acting GLP-1 derivative,substantially reduces fasting and postprandial glycemia in type 2 diabetes显示文摘	Juhl CB Hollingdal M Sturis J	2002	Diabetes2002，51，2：	1
11	Non-insulin-depedent diabetes mellitus a genetically programmed failure of the beta cell to compensate for insulin resistance显示文摘	POLONSKY K STURIS J BELL G I	1996	The New England Journal of Medicine1996，334，：	1
12	One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide(NN2211)markedly improves 24-h glycemia and alpha-and betacell function and reduces endogenous glucose release in patients with type 2 diabetes显示文摘	Degn KB Juhl CB Sturis J	2004	Diabetes2004，53，5：	1
13	GLP-1 derivative liraglutide in rats with b-cell deficiencies:influence of metabolic state on b-cell mass dynamics显示文摘	STURIS J GOTFREDSEN C F ROMER J	2003	Br J Pharmacol2003，140，1：	1
14	Bedtime administration of NN2211,a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes显示文摘	Juhl CB Hollingdal M Sturis J	2002	Diabetes2002，51，：	1
15	Warfarin drug interactions: strategies to minimize adverse drug events显示文摘	Marie A Jilene R Sturis Halhnan I	2011	Nurse Practit2011，7，6：	1
16	Non-insulin-dependentdiabetes mellitus a genetically programmed failure of the beta Cell to compensate for insulin resistance显示文摘	Polonsky K Sturis J Bell GI	1996	N Engl J Med1996，334，：	1
17	One week's treatment with the long-acting glucagons-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha-and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes显示文摘	Degn KB Juhl CB Sturis J	2004	Diabetes2004，53，5：	1
18	GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics显示文摘	Sturis J Gotfredsen CF Romer J	2003	Br J Pharmacol2003，140，1：	1
19	Acute hyper- glycemia alters the ability of the normal 13-cell to sense and respond to glucose显示文摘	Meyer J Sturis J Katschinski M	2002	Am J Physiol Ende- crinol Metab2002，282，：	1
20	American Diabetus Association's 59th显示文摘	Juhl C Poerksen N Sturis J	1999	Scientific Sessions1999，19，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示